Diego Ellerman

8PUBLICATIONS
34CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsMolecular targetsBiologically active moleculesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 13, 2024
The Evolving Applications of Bispecific Antibodies: Reaping the Harvest of Early Sowing and Planting New Seeds.

Diego A Ellerman

|Apr 01, 2022
Novel Anti-LY6G6D/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Colorectal Cancer.

Peiyin Wang, Liping L Sun, Robyn Clark

|Mar 16, 2022
CLEC5a-directed bispecific antibody for effective cellular phagocytosis.

Vivekananda Kedage, Diego Ellerman, Mingjian Fei

|Feb 04, 2021
Anti-LYPD1/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Ovarian Cancer.

Amy A Lo, Jennifer Johnston, Ji Li

|Mar 23, 2019
Immune repertoire mining for rapid affinity optimization of mouse monoclonal antibodies.

Yi-Chun Hsiao, Yonglei Shang, Danielle M DiCara

|Dec 15, 2018
Single cell-produced and in vitro-assembled anti-FcRH5/CD3 T-cell dependent bispecific antibodies have similar in vitro and in vivo properties.

Ayse Meric Ovacik, Ji Li, Marie Lemper

Pageof 2

Frequent Collaborators

3 joint publications

Robyn Clark

3 joint publications

Amy A Lo

3 joint publications

Christoph Spiess

1 joint publications

Dionysos Slaga